Skip to content

SBC Medical Group

US · SBC #3686 by market cap
5.17 -0.43 -7.68%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Price chart

Pre-market 5.51 -1.61%
After-hours 5.10 -1.35%
7.352.875.172026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on SBC?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +53.5% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 0.8% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days B → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 5 of 6 factors. Missing data is not a zero score.

Overall A+

The radar needs all six factors. Available grades are shown below.

Valuation C+

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 10.1x Better than 80%
Forward P/E 14.1x Better than 59%
Price / Sales 4.3x Better than 27%
P/E vs own 5-yr range 87th pctl Better than 18%
Growth B+

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) -0.1% Better than 24%
Net income CAGR (3Y) 100.6% Better than 95%
Profitability A+

How much profit the business keeps from each dollar of sales and capital.

Gross margin 73.3% Better than 85%
Operating margin 38.9% Better than 95%
Net margin 29.4% Better than 89%
Return on equity 23.0% Better than 82%
Return on invested capital 20.1% Better than 90%
Momentum A

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 29.3% Better than 98%
6-month return 68.4% Better than 97%
12-month return (ex latest month) 59.5% Better than 87%
Distance below 52-week high 30.0% Better than 43%
Financial Health B+

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 3.8x Better than 79%
Debt to assets 13.6% Better than 64%
Interest coverage 512.0x Better than 97%
Free cash flow / net income 43.1% Better than 12%
Analyst View N/A

What the Street thinks: share of Buy ratings and upside to the average target.

Not enough data to grade this factor.

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -29.66%
1M -5.31%
3M +40.49%
6M +60.06%
YTD +19.95%
1Y +66.51%
3Y -51.46%

Key statistics

Price & volume

Prev close
5.60
Open
5.50
Day range
5.03 - 5.53
Avg price
5.22
Volume
377.69K
Turnover
1.97M
Amplitude
8.96%
52-week range
2.78 - 7.39

Valuation

P/E
10.34
P/E (TTM)
10.14
P/B
1.85
EPS
0.50
Net profit
51.42M
Net assets
286.84M

Share structure

Market cap
531.72M
Float cap
93.60M
Shares out
102.85M
Float shares
18.10M

Dividend & listing

Dividend (TTM)
0.00
Listing date
--
52-week range 52% of range
2.78 7.39

30.0% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-153.57K net over the window

Short interest

Shares short
840.71K
As of
2026-10-30

Frequently asked questions

What is the current stock price of SBC Medical Group (SBC)?

SBC Medical Group last traded at 5.17. This page shows a periodic quote snapshot. Check the displayed quote time.

What is SBC Medical Group's market cap?

About 531.72M.

What is the P/E ratio of SBC Medical Group?

The trailing twelve-month P/E is 10.14, below its own 5-year average of 13.12 — toward the top of its historical range (87.11% percentile). See the Valuation tab for the full history.

Does SBC Medical Group pay a dividend?

SBC Medical Group does not currently pay a regular dividend.

Is SBC Medical Group a buy according to analysts?

The consensus of 2 analysts is a Buy rating, with an average 12-month price target of 8.50, which implies 64.4% upside from the current price. This is not investment advice.

What is SBC Medical Group's StockVane Quant Rating?

The StockVane Momentum strategy currently rates SBC Medical Group a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 20:02:39 · For reference only, not investment advice and not tailored to your situation.

SBC Medical Group discussion 0 comments

Add a comment